Steve Miller - 11 Dec 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Op. & Scientific Officer
Signature
/s/ Steve Miller
Issuer symbol
CPRX
Transactions as of
11 Dec 2023
Net transactions value
+$169,500
Form type
4
Filing time
13 Dec 2023, 17:00:23 UTC
Previous filing
12 Dec 2023
Next filing
29 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $169,500 +150,000 +23% $1.13* 797,457 11 Dec 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -150,000 -8.3% $0.000000 1,648,956 11 Dec 2023 Common Stock 150,000 $1.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vested in three annual tranches beginning on January 3, 2018.